Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.
about
Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials.Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancerA pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.
P2860
Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Outcomes of patients with adva ...... r treated in a phase I clinic.
@ast
Outcomes of patients with adva ...... r treated in a phase I clinic.
@en
type
label
Outcomes of patients with adva ...... r treated in a phase I clinic.
@ast
Outcomes of patients with adva ...... r treated in a phase I clinic.
@en
prefLabel
Outcomes of patients with adva ...... r treated in a phase I clinic.
@ast
Outcomes of patients with adva ...... r treated in a phase I clinic.
@en
P2093
P2860
P50
P1433
P1476
Outcomes of patients with adva ...... r treated in a phase I clinic.
@en
P2093
David S Hong
Henrique A Parsons
Ralph G Zinner
Xuemei Wang
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0308
P577
2011-02-21T00:00:00Z